Your browser doesn't support javascript.
loading
Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors.
Yadav, Manish K; Maharana, Jagannath; Yadav, Ravi; Saha, Shirsha; Sarma, Parishmita; Soni, Chahat; Singh, Vinay; Saha, Sayantan; Ganguly, Manisankar; Li, Xaria X; Mohapatra, Samanwita; Mishra, Sudha; Khant, Htet A; Chami, Mohamed; Woodruff, Trent M; Banerjee, Ramanuj; Shukla, Arun K; Gati, Cornelius.
Afiliação
  • Yadav MK; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Maharana J; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Yadav R; Molecular and Computational Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA; The Bridge Institute, Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA, USA.
  • Saha S; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Sarma P; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Soni C; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Singh V; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Saha S; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Ganguly M; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Li XX; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Mohapatra S; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Mishra S; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.
  • Khant HA; USC Center of Excellence for Nano-Imaging, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA.
  • Chami M; BioEM Lab, Biozentrum, Universität Basel, Basel, Switzerland.
  • Woodruff TM; School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Banerjee R; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India. Electronic address: ramanujb@iitk.ac.in.
  • Shukla AK; Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India. Electronic address: arshukla@iitk.ac.in.
  • Gati C; Molecular and Computational Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA; The Bridge Institute, Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA, USA; Department of Chemistry, Department of
Cell ; 186(22): 4956-4973.e21, 2023 10 26.
Article em En | MEDLINE | ID: mdl-37852260
ABSTRACT
The complement system is a critical part of our innate immune response, and the terminal products of this cascade, anaphylatoxins C3a and C5a, exert their physiological and pathophysiological responses primarily via two GPCRs, C3aR and C5aR1. However, the molecular mechanism of ligand recognition, activation, and signaling bias of these receptors remains mostly elusive. Here, we present nine cryo-EM structures of C3aR and C5aR1 activated by their natural and synthetic agonists, which reveal distinct binding pocket topologies of complement anaphylatoxins and provide key insights into receptor activation and transducer coupling. We also uncover the structural basis of a naturally occurring mechanism to dampen the inflammatory response of C5a via proteolytic cleavage of the terminal arginine and the G-protein signaling bias elicited by a peptide agonist of C3aR identified here. In summary, our study elucidates the innerworkings of the complement anaphylatoxin receptors and should facilitate structure-guided drug discovery to target these receptors in a spectrum of disorders.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Complemento / Transdução de Sinais / Anafilatoxinas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Complemento / Transdução de Sinais / Anafilatoxinas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article